SCHEMBL18005802

SCHEMBL18005802

N#Cc1[nH]nnc1Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.40
AR P10275 1/20 0.40
HPGD P15428 4/20 0.39
CYP2C9 P11712 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LTB4R Q15722 1/20 0.39
CALM1 P0DP23 1/20 0.38
SMO Q99835 4/20 0.38
KDM5A P29375 1/20 0.38
HTR2C P28335 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 3/20 0.36
BCAT2 O15382 1/20 0.36
MAPT P10636 1/20 0.36
GAA P10253 1/20 0.35
CYP2D6 P10635 1/20 0.35
FPR1 P21462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18005807 0.86 GRIN1 (0.45) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL18006510 0.84 PARP1 (0.41) PARP1HPGDALDH1A1KDM5AHTT
SCHEMBL18006513 0.80 TSHR (0.47) KDM4ETSHRNPC1RAB9ASMN1; SMN2
SCHEMBL18006124 0.77 CNR2 (0.38) HPGDCALM1MEN1KMT2ATSHR
Water SCHEMBL8182334 0.76 PARP1 (0.42) PARP1ARHPGDCYP2C9ALDH1A1
SCHEMBL1203617 0.76 LTB4R (0.50) PARP1ARHPGDCYP2C9ALDH1A1
SCHEMBL305311 0.74 PARP1 (0.42) PARP1ARHPGDCYP2C9ALDH1A1
SCHEMBL9525223 0.74 LTB4R (0.49) PARP1ARHPGDCYP2C9ALDH1A1
SCHEMBL21531465 0.74 CALM1 (0.46) PARP1ARHPGDCYP2C9ALDH1A1
SCHEMBL5600491 0.74 HTR2C (0.45) PARP1ARHPGDCYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 EP disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626095-B2 Cyanotriazole compounds CS, PC, ACAT1 PARP1 3331/4885AR 3449/4885HPGD 2152/4885
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS CS, PC, ACAT1 PARP1 3331/4885AR 3449/4885HPGD 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.